- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07742462
The Effects of Interval Sprint Training on Physical Performance and Competition Anxiety in College Soccer Players
July 29, 2026 updated by: Xiang Gao
The Effects of Interval Sprint Training on Physical Performance and Competition Anxiety in College Soccer Players: A Randomized Controlled Trial
To investigate the comprehensive effects of structured repeated sprint training (RST) on the multidimensional physical performance and competition-related anxiety of college soccer players.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510000
- Guangzhou Sport University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age 18-24 years;
- At least 3 years of systematic soccer training;
- No history of severe lower-limb sports injuries within the past 6 months (defined as injuries resulting in ≥4 weeks of training cessation);
- No participation in any form of repeated sprinting or high-intensity interval training programs during the 2 months prior to the study.
Exclusion Criteria:
- Presence of any cardiovascular, metabolic, or musculoskeletal conditions that may affect testing or training;
- Inability to guarantee attendance during the study period (expected number of absences > 2).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
|
In Weeks 1-3, they completed 1 set of 8 × 30-meter straight-line sprints, with a 30-second rest after each sprint; in Weeks 4-6, the workload was increased to 2 sets of 8 × 30-meter sprints, with a 30-second rest between sprints within each set and a 3-minute rest between sets
|
|
Sham Comparator: Control Group
|
Sham
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
20-meter straight-line sprint
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 4, 2024
Primary Completion (Actual)
December 13, 2024
Study Completion (Actual)
December 13, 2024
Study Registration Dates
First Submitted
July 29, 2026
First Submitted That Met QC Criteria
July 29, 2026
First Posted (Actual)
August 3, 2026
Study Record Updates
Last Update Posted (Actual)
August 3, 2026
Last Update Submitted That Met QC Criteria
July 29, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023LCLL-12
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.